JPRN-jRCT2080222569未知3 期
Phase3 comparative confirmatory study of K-877 against fenofibrate
适应症
试验速览
- 阶段
- 3 期
- 入组人数
- 225
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •(1)Patients who have been placed on dietary or exercise therapy for 12 weeks or longer prior to the initiation of treatment period
- •(2)men or postmenopausal women
- •(3)20 years or older at the time of informed consent
排除标准
- •(1)Type 1 diabetes mellitus or poorly controlled Type 2 diabetes mellitus
- •-HbA1c(NGSP): >= 8.0%(at the screening test)
- •(2)Poorly controlled hypertension
- •-SBP: >=160 and/or DBP: >=100 mmHg (at the screening test)
- •(3)Poorly controlled thyroid disorder
研究者
相似试验
已完成
3 期
A Phase III Confirmatory Study of K-877 Extended Release TabletDyslipidemiaJPRN-jRCT2051200128Tanigawa Ryohei345
招募中
3 期
A Phase III Confirmatory Study of K-877 (Pemafibrate) in Patients with Hypercholesterolemia and Statin IntoleranceHypercholesterolemiaJPRN-jRCT2051230055Tanigawa Ryohei60
进行中（未招募）
3 期
A Phase III Confirmatory Study of K-237COVID-19JPRN-jRCT2031210316Tanigawa Ryohei1,000
未知
2 期
A phase 2 dose exploratory study of K-877DyslipidemiaJPRN-jRCT2080221294Kowa Co., Ltd.192
未知
3 期
Comparative confirmatory study of K-877 against fenofibrateDyslipidemiaJPRN-jRCT2080221722Kowa Co., Ltd.480